V W Byrnes

466 total citations
8 papers, 319 citations indexed

About

V W Byrnes is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, V W Byrnes has authored 8 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Virology, 7 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in V W Byrnes's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (4 papers). V W Byrnes is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (4 papers). V W Byrnes collaborates with scholars based in United States and France. V W Byrnes's co-authors include William A. Schleif, Emilio A. Emini, Jon H. Condra, Christine L. Schneider, Jill Wolfgang, William J. Long, A J Schlabach, Vinod Sardana, Michael S. Saag and Kevin W. Anderson and has published in prestigious journals such as New England Journal of Medicine, Journal of Virology and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

V W Byrnes

8 papers receiving 308 citations

Peers

Countries citing papers authored by V W Byrnes

Since Specialization

Citations

This map shows the geographic impact of V W Byrnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V W Byrnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V W Byrnes more than expected).

Fields of papers citing papers by V W Byrnes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V W Byrnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V W Byrnes. The network helps show where V W Byrnes may publish in the future.

Co-authorship network of co-authors of V W Byrnes

This figure shows the co-authorship network connecting the top 25 collaborators of V W Byrnes. A scholar is included among the top collaborators of V W Byrnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V W Byrnes. V W Byrnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	[19] A system to analyze and identify inhibitors of HIV-1 gene regulation using a defective integrated provirus 1996 ·Methods in enzymology on CD-ROM/Methods in enzymology ·V W Byrnes, (unknown)	2
2	Turnover of circulating virion RNA and of cell-associated viral DNA reflects active viral replication in human immunodeficiency virus type 1-infected individuals 1995 ·Journal of Virology ·D W Lineberger, Joseph Kessler, Julie A. Waterbury, V W Byrnes, F Massari, Schlomo Staszewski, Emilio A. Emini	6
3	Attempted Prophylaxis of Human Immunodeficiency Virus Type 1 Infection in Chimpanzees with a Nonnucleoside Reverse Transcriptase Inhibitor 1994 ·AIDS Research and Human Retroviruses ·William A. Schleif, KRISHNA K. MURTHY, Vinod Sardana, Christine L. Schneider, V W Byrnes, KATHY E. COBB, Elizabeth Röth, Jill Wolfgang, J. M. HOFFMAN, (unknown), (unknown), Emilio A. Emini	4
4	The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors 1994 ·PubMed ·Emilio A. Emini, V W Byrnes, Jon H. Condra, William A. Schleif, Vinod Sardana	5
5	Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors 1994 ·Antimicrobial Agents and Chemotherapy ·V W Byrnes, Emilio A. Emini, William A. Schleif, Jon H. Condra, Christine L. Schneider, William J. Long, Jill Wolfgang, Donald J. Graham, L Gotlib, A J Schlabach	57
6	A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase 1993 ·New England Journal of Medicine ·Michael S. Saag, Emilio A. Emini, Oscar L. Laskin, Jeffrey A. Douglas, (unknown), William A. Schleif, Richard J. Whitley, (unknown), V W Byrnes, John C. Kappes, Kevin W. Anderson, F Massari, George M. Shaw	125
7	Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors 1993 ·Antimicrobial Agents and Chemotherapy ·V W Byrnes, Vinod Sardana, William A. Schleif, Jon H. Condra, Julie A. Waterbury, Jill Wolfgang, William J. Long, Christine L. Schneider, A J Schlabach, B. Wolanski	95
8	A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors 1993 ·Antimicrobial Agents and Chemotherapy ·Mark E. Goldman, J A O'Brien, (unknown), William A. Schleif, Vinod Sardana, V W Byrnes, Jon H. Condra, J. M. HOFFMAN, Emilio A. Emini	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact